You can buy or sell OTLKW and other stocks, options, ETFs, and crypto commission-free!
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. Read More It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.
Cranbury, New Jersey
52 Week High
52 Week Low